Skip to content
    Merck Global Health Innovation Fund logo

    Merck Global Health Innovation Fund

    Rahway, United StatesFounded 2010
    www.merckghifund.com
    HealthcareBiotech & Life SciencesData & Analytics

    Merck Global Health Innovation Fund (MGHIF) is the corporate venture capital arm of Merck & Co., founded in 2010 and based in Rahway, New Jersey. It is a growth investor partnering with innovative digital health and data science companies that facilitate and optimize biopharmaceutical operations and enhance patient care.

    40% of their portfolio is in Healthcare. Average disclosed round size is $49.2M (across 62 rounds with reported amounts).

    Find people at Merck Global Health Innovation Fund on Goldilocks AI

    Portfolio

    51

    Fund Size

    $500M

    Top Stage

    Series B

    Last 12 Mo

    2

    Team

    BT

    Bill Taranto

    President & General Partner

    DR

    David Rubin

    Managing Director

    JV

    Joe Volpe

    VP / Managing Director

    JK

    Joel Krikston

    Managing Director Venture Investments

    PT

    Prem Tumkosit

    Managing Director

    AZ

    Alba Zurriaga Carda

    Director of Investments

    MM

    Michael Morgan

    Principal

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    70 investments
    CompanyRoundAmountDate
    BBigHatSeries C$75MSep 2026
    Unnatural Products logoUnnatural ProductsSeries B$45MMar 2026
    UUnnatural Products Inc.Series B$45MJan 2026
    PreciseDx logoPreciseDxUnknown$11MJun 2025
    VVariational AISeed$5.5MFeb 2025
    Qure.ai logoQure.aiSeries D$65MSep 2024
    PreciseDx logoPreciseDxSeries B$20.7MAug 2024
    Qure.ai logoQure.aiSeries D—Jun 2024
    CargoSense logoCargoSenseSeries A$8MJun 2024
    Delfi Diagnostics, Inc. logoDelfi Diagnostics, Inc.Unknown—Jun 2024
    Atropos Health logoAtropos HealthSeries B—May 2024
    AAtroposSeries B$33MMay 2024
    ZZapata Computing, Inc.Series B$38MMay 2024
    Transcarent logoTranscarentSeries D$126MMay 2024
    Transcarent logoTranscarentSeries D$126MJan 2024
    Unnatural Products logoUnnatural ProductsSeries A$32MDec 2023
    UUnnatural Products Inc.Series A$32MDec 2023
    AeroSafe Global logoAeroSafe GlobalGrowth$43MAug 2023
    AAeroSafeSeries F$43MAug 2023
    Prognos Health logoPrognos HealthGrowth$23MJan 2023
    Unnatural Products logoUnnatural ProductsSeries A$32MJan 2023
    Koneksa Health logoKoneksa HealthSeries C$45MFeb 2022
    Verana Health logoVerana HealthSeries E$150MJan 2022
    VVeranaSeries E$150MJan 2022
    Transcarent logoTranscarentSeries C—Jan 2022
    Page 1 of 3

    Top Co-Investors

    Labcorp9 shared
    General Catalyst8 shared
    Merck8 shared
    Breyer Capital6 shared
    Threshold Ventures6 shared
    Casdin Capital5 shared
    The Venture Collective5 shared
    McKesson Ventures5 shared
    Alta Partners5 shared
    Safeguard Scientifics, Inc.5 shared
    THVC4 shared
    GV4 shared
    Johnson & Johnson Innovation4 shared
    Human Ventures4 shared
    Kinnevik4 shared
    Geodesic Capital4 shared
    Leaps by Bayer4 shared
    Ally Bridge Group4 shared
    Amgen Ventures4 shared
    The Cigna Group Ventures4 shared

    Last updated: 20 October 2026